183 related articles for article (PubMed ID: 15197549)
1. Impact of FDG-PET for staging of oesophageal cancer.
Imdahl A; Hentschel M; Kleimaier M; Hopt UT; Brink I
Langenbecks Arch Surg; 2004 Aug; 389(4):283-8. PubMed ID: 15197549
[TBL] [Abstract][Full Text] [Related]
2. Limited additional value of positron emission tomography in staging oesophageal cancer.
van Westreenen HL; Westerterp M; Sloof GW; Groen H; Bossuyt PM; Jager PL; Comans EF; van Dullemen HM; Fockens P; Stoker J; van der Jagt EJ; van Lanschot JJ; Plukker JT
Br J Surg; 2007 Dec; 94(12):1515-20. PubMed ID: 17902092
[TBL] [Abstract][Full Text] [Related]
3. Fluorine-18 fluorodeoxyglucose positron emission tomography in the preoperative staging of thoracic oesophageal and gastro-oesophageal junction cancer: a prospective study.
Katsoulis IE; Wong WL; Mattheou AK; Damani N; Chambers J; Livingstone JI
Int J Surg; 2007 Dec; 5(6):399-403. PubMed ID: 17631431
[TBL] [Abstract][Full Text] [Related]
4. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma.
Kato H; Miyazaki T; Nakajima M; Takita J; Kimura H; Faried A; Sohda M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H; Oriuchi N; Endo K
Cancer; 2005 Jan; 103(1):148-56. PubMed ID: 15558794
[TBL] [Abstract][Full Text] [Related]
5. Value of positron emission tomography in the diagnosis of recurrent oesophageal carcinoma.
Kato H; Miyazaki T; Nakajima M; Fukuchi M; Manda R; Kuwano H
Br J Surg; 2004 Aug; 91(8):1004-9. PubMed ID: 15286962
[TBL] [Abstract][Full Text] [Related]
6. [Positron emission tomography for the preoperative staging of esophageal carcinoma].
Junginger T; Kneist W; Schreckenberger M; Menzel C; Oberholzer K; Bartenstein P
Dtsch Med Wochenschr; 2002 Sep; 127(38):1935-41. PubMed ID: 12239652
[TBL] [Abstract][Full Text] [Related]
7. Computed tomography and positron emission tomography in the pre-operative staging of oesophageal carcinoma.
Rankin SC; Taylor H; Cook GJ; Mason R
Clin Radiol; 1998 Sep; 53(9):659-65. PubMed ID: 9766719
[TBL] [Abstract][Full Text] [Related]
8. The role of PET scan in the preoperative management of oesophageal cancer.
Liberale G; Van Laethem JL; Gay F; Goldman S; Nagy N; Coppens E; Gelin M; El Nakadi I
Eur J Surg Oncol; 2004 Nov; 30(9):942-7. PubMed ID: 15498638
[TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer.
Flamen P; Van Cutsem E; Lerut A; Cambier JP; Haustermans K; Bormans G; De Leyn P; Van Raemdonck D; De Wever W; Ectors N; Maes A; Mortelmans L
Ann Oncol; 2002 Mar; 13(3):361-8. PubMed ID: 11996465
[TBL] [Abstract][Full Text] [Related]
10. Impact of the introduction of integrated PET-CT into the preoperative staging pathway of patients with potentially operable oesophageal carcinoma.
Salahudeen HM; Balan A; Naik K; Mirsadraee S; Scarsbrook AF
Clin Radiol; 2008 Jul; 63(7):765-73. PubMed ID: 18555034
[TBL] [Abstract][Full Text] [Related]
11. Pitfalls of positive findings in staging esophageal cancer with F-18-fluorodeoxyglucose positron emission tomography.
van Westreenen HL; Heeren PA; Jager PL; van Dullemen HM; Groen H; Plukker JT
Ann Surg Oncol; 2003 Nov; 10(9):1100-5. PubMed ID: 14597450
[TBL] [Abstract][Full Text] [Related]
12. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma.
Flamen P; Lerut A; Van Cutsem E; De Wever W; Peeters M; Stroobants S; Dupont P; Bormans G; Hiele M; De Leyn P; Van Raemdonck D; Coosemans W; Ectors N; Haustermans K; Mortelmans L
J Clin Oncol; 2000 Sep; 18(18):3202-10. PubMed ID: 10986052
[TBL] [Abstract][Full Text] [Related]
13. The utility of positron emission tomography in staging of potentially operable carcinoma of the thoracic esophagus: results of the American College of Surgeons Oncology Group Z0060 trial.
Meyers BF; Downey RJ; Decker PA; Keenan RJ; Siegel BA; Cerfolio RJ; Landreneau RJ; Reed CE; Balfe DM; Dehdashti F; Ballman KV; Rusch VW; Putnam JB;
J Thorac Cardiovasc Surg; 2007 Mar; 133(3):738-45. PubMed ID: 17320575
[TBL] [Abstract][Full Text] [Related]
14. Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma.
Kato H; Kuwano H; Nakajima M; Miyazaki T; Yoshikawa M; Ojima H; Tsukada K; Oriuchi N; Inoue T; Endo K
Cancer; 2002 Feb; 94(4):921-8. PubMed ID: 11920459
[TBL] [Abstract][Full Text] [Related]
15. Limitations of FDG-PET and FDG-PET with computed tomography for detecting synchronous cancer in pharyngeal cancer.
Suzuki H; Hasegawa Y; Terada A; Ogawa T; Hyodo I; Suzuki M; Nakashima T; Tamaki T; Nishio M
Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1191-5. PubMed ID: 19015450
[TBL] [Abstract][Full Text] [Related]
16. Additional benefit of ¹⁸F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer.
Gillies RS; Middleton MR; Maynard ND; Bradley KM; Gleeson FV
Eur Radiol; 2011 Feb; 21(2):274-80. PubMed ID: 20821013
[TBL] [Abstract][Full Text] [Related]
17. The decision to operate: role of integrated computed tomography positron emission tomography in staging oesophageal and oesophagogastric junction cancer by the multidisciplinary team.
Berrisford RG; Wong WL; Day D; Toy E; Napier M; Mitchell K; Wajed S
Eur J Cardiothorac Surg; 2008 Jun; 33(6):1112-6. PubMed ID: 18328726
[TBL] [Abstract][Full Text] [Related]
18. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
[TBL] [Abstract][Full Text] [Related]
19. [Positron emission tomography for preoperative lymph node diagnosis in esophageal carcinoma].
Kneist W; Schreckenberger M; Bartenstein P; Grünwald F; Oberholzer K; Junginger T
Chirurg; 2003 Oct; 74(10):922-30; discussion 929-30. PubMed ID: 14605734
[TBL] [Abstract][Full Text] [Related]
20. Role of positron emission tomography in the (re-)staging of oesophageal cancer.
Westerterp M; Van Westreenen HL; Sloof GW; Plukker JT; Van Lanschot JJ
Scand J Gastroenterol Suppl; 2006; (243):116-22. PubMed ID: 16782630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
